News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
The EORTC 2023 Annual Report is now available!
Photo from EORTC/LinkedIn
Jun 20, 2024, 10:52

The EORTC 2023 Annual Report is now available!

The European Organisation for Research and Treatment of Cancer (EORTC), shared on LinkedIn:

“The EORTC 2023 Annual Report is now available.

Many thanks to everyone who supports us and believes in our mission of improving the survival and quality of life of all cancer patients.

Explore the full Annual Report to learn more.”

Source: EORTC/LinkedIn

Annual Report cancer EORTC European Organisation for Research and Treatment of Cancer OncoDaily Oncology
Blog
Aug 9, 2024, 18:07
5th Scientific Workshop - ESHMICRO2025
Insight
Aug 9, 2024, 18:04
Meyer May-Lucie: New publication in The Lancet reviewing the treatment of advanced lung cancer
Insight
Aug 9, 2024, 17:56
Yu Fujiwara: ASCO Breakthrough to Highlight Advances in Esophageal, Nasopharyngeal, Lung Cancers
Blog
Aug 9, 2024, 17:54
Robin Zon: Wonderful first day of ASCOBT24
Insight
Aug 9, 2024, 17:49
Soraia Lobo-Martins: Tumour Heterogeneity in Molecular Imaging for Breast Cancer
Insight
Aug 9, 2024, 17:49
Cancer survivors are at a significant risk of CVD-related mortality
Blog
Aug 9, 2024, 17:27
Kimryn Rathmell: Our gold medals are the scientific advances that give someone more time with their loved ones
Insight
Aug 9, 2024, 17:20
Denis Wirtz: Taking a precancerous lesion for a spin
Insight
Aug 9, 2024, 17:20
Hyun Kim: Y-90 in arterially hypoperfused tumors in primary hepatic malignancies
Blog
Aug 9, 2024, 17:12
Annual Teddy Bear Clinic of the Children's Cancer Hospital at MD Anderson Cancer Center
Insight
Aug 9, 2024, 16:57
Khalid El Bairi: Jewel edited by Sarah Elaine Eaton - The Second Hand Book of Academic Integrity
Blog
Aug 9, 2024, 16:38
Albert Koong: PFS of 10.3 month vs. 2.5 month in Pancreas Cancer patients with oligometastatic disease